Pharmesis International Ltd. is a Singapore-based investment holding company. The Company is a pharmaceutical company engaged in the manufacturing of pharmaceutical products, including western medicine in the form of tablets and granules, among others, and traditional Chinese medicine (TCM) formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates in three segments: Western drugs, which refers mainly to chemically formulated drugs marketed under the Kinna brand; TCM formulated drugs, which includes TCM marketed under the Longlife brand, and Distribution, which includes agency products and internally manufactured products marketed through the distribution arm. Its main products are ATT, Gulin Gansu and Er Ding granules. Its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd, is engaged in the development, manufacture, packaging and sale of western medicines and health tonic products.
|Kwok Kee Chay||65||2018||Independent Non-Executive Director|
|Chia-Jung Chung||28||2017||Non-Independent Non-Executive Director|
|Lai Yin Chan||-||2010||Joint Company Secretary|
|Pay Lee Lee||-||2015||Company Secretary|
|Heng Ching Chew||66||2015||Lead Independent Non-Executive Director|
|Chan Hoe Liang||39||2016||Financial Controller|
|Jie Qi||51||2018||Chief Operating Officer, Executive Director|
|Xuedan Wu||55||2017||Chief Executive Officer, Executive Director|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.